Axa’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,571
Closed -$8.65M 505
2025
Q2
$8.65M Sell
22,571
-19,858
-47% -$7.16M 0.02% 426
2025
Q1
$14.7M Buy
42,429
+25,531
+151% +$8.21M 0.05% 318
2024
Q4
$5.07M Sell
16,898
-20,175
-54% -$7.05M 0.02% 537
2024
Q3
$15.1M Buy
37,073
+10,342
+39% +$3.79M 0.04% 332
2024
Q2
$8.59M Sell
26,731
-29,112
-52% -$9.46M 0.03% 411
2024
Q1
$18.6M Sell
55,843
-11,803
-17% -$3.61M 0.06% 294
2023
Q4
$18.3M Sell
67,646
-31,477
-32% -$7.78M 0.06% 292
2023
Q3
$24.4M Sell
99,123
-12,623
-11% -$3.45M 0.09% 234
2023
Q2
$33.9M Sell
111,746
-580
-0.5% -$161K 0.11% 199
2023
Q1
$29.6M Sell
112,326
-51,903
-32% -$13.2M 0.1% 225
2022
Q4
$39.4M Sell
164,229
-34,205
-17% -$7.66M 0.14% 175
2022
Q3
$36.5M Buy
198,434
+68,783
+53% +$13.7M 0.14% 167
2022
Q2
$21.8M Sell
129,651
-27,182
-17% -$5.84M 0.08% 275
2022
Q1
$39.3M Buy
156,833
+15,888
+11% +$3.99M 0.11% 205
2021
Q4
$36.2M Sell
140,945
-60,967
-30% -$14.9M 0.09% 247
2021
Q3
$49M Sell
201,912
-17,151
-8% -$4.19M 0.14% 183
2021
Q2
$45.3M Sell
219,063
-13,507
-6% -$2.75M 0.13% 184
2021
Q1
$43.8M Buy
232,570
+10,096
+5% +$1.78M 0.13% 197
2020
Q4
$36.6M Buy
222,474
+18,509
+9% +$2.71M 0.11% 205
2020
Q3
$25.4M Sell
203,965
-73,340
-26% -$9.08M 0.09% 249
2020
Q2
$26.9M Buy
277,305
+43,178
+18% +$4.49M 0.11% 224
2020
Q1
$21M Sell
234,127
-1,133
-0.5% -$147K 0.11% 221
2019
Q4
$34.8M Buy
235,260
+92,179
+64% +$12.4M 0.14% 182
2019
Q3
$17.2M Buy
143,081
+2,323
+2% +$300K 0.07% 340
2019
Q2
$19M Buy
140,758
+1,258
+0.9% +$159K 0.07% 308
2019
Q1
$18.2M Sell
139,500
-52,870
-27% -$7.1M 0.07% 322
2018
Q4
$23.9M Buy
192,370
+31,979
+20% +$4.29M 0.1% 245
2018
Q3
$22.3M Buy
160,391
+26,900
+20% +$3.35M 0.08% 277
2018
Q2
$13.7M Sell
133,491
-909
-0.7% -$92K 0.05% 365
2018
Q1
$13M Sell
134,400
-16,400
-11% -$1.59M 0.05% 373
2017
Q4
$13.2M Sell
150,800
-87,900
-37% -$7.06M 0.05% 381
2017
Q3
$19M Sell
238,700
-72,600
-23% -$5.84M 0.08% 284
2017
Q2
$27.1M Sell
311,300
-600,800
-66% -$50.8M 0.12% 218
2017
Q1
$81.2M Sell
912,100
-10,300
-1% -$859K 0.37% 65
2016
Q4
$68.3M Buy
922,400
+83,500
+10% +$6.25M 0.32% 83
2016
Q3
$63.4M Sell
838,900
-648,768
-44% -$49.7M 0.28% 103
2016
Q2
$115M Buy
1,487,668
+162,948
+12% +$12.9M 0.51% 38
2016
Q1
$103M Buy
1,324,720
+761,920
+135% +$53.2M 0.46% 50
2015
Q4
$38.1M Sell
562,800
-1,319,931
-70% -$92.1M 0.17% 174
2015
Q3
$146M Buy
1,882,731
+624,980
+50% +$55.3M 0.6% 29
2015
Q2
$114M Buy
1,257,751
+1,067,150
+560% +$85.5M 0.46% 44
2015
Q1
$14.3M Sell
190,601
-160,090
-46% -$11.5M 0.06% 324
2014
Q4
$25.7M Sell
350,691
-60,251
-15% -$4.23M 0.1% 223
2014
Q3
$29M Buy
410,942
+121,666
+42% +$8.04M 0.12% 207
2014
Q2
$16.3M Buy
289,276
+71,761
+33% +$3.79M 0.07% 306
2014
Q1
$11.4M Buy
217,515
+102,605
+89% +$5.11M 0.05% 356
2013
Q4
$5.48M Buy
114,910
+2,817
+3% +$130K 0.02% 498
2013
Q3
$4.79M Buy
112,093
+413
+0.4% +$16.1K 0.02% 524
2013
Q2
$4.03M Buy
+111,680
New +$4.32M 0.02% 524

Other funds holding HCA

Axa's HCA Position: Q3 2025 in Review

Axa sold out of HCA Healthcare (HCA) in Q3 2025, closing a stake of 22,571 shares — an estimated $8.65M sold.

Axa first reported a position in HCA in Q2 2013 and held it in 49 quarters. The position peaked at $146M in Q3 2015. 1,287 funds tracked by Wall St. Rank hold HCA as of Q3 2025.

  • Axa reported no remaining HCA Healthcare position as of Q3 2025 after selling out during the quarter.
  • Axa sold 22,571 HCA Healthcare shares in Q3 2025, an estimated $8.65M.
  • Axa first reported a position in HCA Healthcare in Q2 2013 and held it in 49 quarters.
  • Axa's HCA Healthcare position peaked at $146M in Q3 2015.
  • 1,287 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.